220875-88-7

Basic information

• Product Name: 4-(chloromethyl)-N-methylbenzamide
• Synonyms: 4-(chloromethyl)-N-methylbenzamide;4-(chloromethyl)-N-methylbenzamide(SALTDATA: FREE)
• CAS NO: 220875-88-7
• Molecular Formula: C₉H₁₀ClNO
• Molecular Weight: 183.6348
• Mol File: 220875-88-7.mol

Chemical Properties

• Boiling Point: 346.917°C at 760 mmHg
• Flash Point: 163.61°C
• Appearance: /
• Density: 1.166g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.543
• CAS DataBase Reference: 4-(chloromethyl)-N-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(chloromethyl)-N-methylbenzamide(220875-88-7)
• EPA Substance Registry System: 4-(chloromethyl)-N-methylbenzamide(220875-88-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 220875-88-7(Hazardous Substances Data)

Usage

Uses

Used in Research and Chemical Synthesis:
4-(chloromethyl)-N-methylbenzamide is utilized as a research chemical and intermediate in chemical synthesis for the development of new compounds and materials. Its unique structure allows for further functionalization and modification, making it a valuable building block in organic chemistry.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(chloromethyl)-N-methylbenzamide is used as a potential candidate for drug discovery and development. Its chemical properties and reactivity may contribute to the design of new therapeutic agents, although further research is required to assess its efficacy, safety, and potential applications in medicine.
Used in Agrochemical Industry:
4-(chloromethyl)-N-methylbenzamide may also have potential applications in the agrochemical industry, where it could be used as a starting material or intermediate for the synthesis of new pesticides, herbicides, or other agrochemical products. Its reactivity and functional groups may offer advantages in the development of novel and effective agricultural chemicals.
Other Industrial Uses:
Beyond the pharmaceutical and agrochemical industries, 4-(chloromethyl)-N-methylbenzamide may find applications in other areas, such as materials science, where its unique structure could be leveraged to create new polymers or coatings with specific properties. However, further research is needed to fully understand its potential and safety profile in these applications.

InChI:InChI=1/C9H10ClNO/c1-11-9(12)8-4-2-7(6-10)3-5-8/h2-5H,6H2,1H3,(H,11,12)

Upstream product

• 876-08-4 p-(chloromethyl)benzoyl chloride 
• 593-51-1 methylamine hydrochloride 
• 1642-81-5 p-(chloromethyl)benzoic acid 
• 74-89-5 methylamine 
• 99-94-5 p-Toluic acid 

Downstream Products

• 1610612-03-7 N-methyl-4-((trimethylstannyl)methyl)benzamide 
• 220875-89-8 4-(1-methyltetrazol-5-yl)benzyl chloride 

Relevant articles and documents

The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds with a chlorodifluoroethyl iodonium salt (CDFI)

Herein, we report a simple and efficient method for the direct installation of chlorodifluoroethyl group onto aromatic molecules of various aromatic amides with a new 2-chloro,2,2-difluoroethyl(mesityl)iodonium salt (CDFI). Moreover, the chlorodifluoroeth

INDOL AND INDAZOL DERIVATIVES

The present invention relates to indole and indazole derivatives of the following formula (I) wherein A is (AA) and the remaining variables are as defined in the specification. The compounds may be used for the treatment or prophylaxis of Alzheimer's disease, cognitive impairment, schizophrenia, pain or sleep disorders.

COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES

The present invention provides compounds of formula I: [INSERT FORMULA HERE] or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.

NAPHTHYLACETIC ACIDS

The invention is concerned with the compounds of formula (I) and pharmaceutically acceptable salts and esters thereof, wherein X, Q, and R1-R6 are defined in the detailed description and claims. In addition, the present invention relates to methods of manufacturing and using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds of formula (I) are antagonists or partial agonists at the CRTH2 receptor and may be useful in treating diseases and disorders associated with that receptor such as asthma.

N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.

A systematic structure-activity relationship investigation of the lead compound 1 resulted the identification of several N-[(substituted alkyl)cycloalkanoyl]-4-[((2,6-dichlorophenyl)carbonyl)amino]-L-phenylalanine derivatives as potent VCAM/VLA-4 antagonists. The data are consistent with a model of these compounds in which these alkanoylphenylalanines reside in a compact gauche (-) bioactive conformation.

N-alkanoylphenylalanine derivatives

Compounds of the formula: are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.